Diabetes Drug Safety: Doctors Get Good And Bad News
AstraZeneca and Bristol had already given headline results from the study in June, showing Onglyza did not increase heart
diabete drug safety doctor good bad news astrazeneca bristol give headline result study june show onglyza increase heart